Measuring phospho-MET by multiplex immunofluorescence to aid in selection of patients with MET activation in tumors.

3131Background: Currently, patient selection criteria for clinical testing of MET inhibitors are limited. Robust studies selecting patients based on MET protein expression, MET gene amplification, ...